Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581594 · ClinicalTrials.gov registry record · NA
Traditional vs. Graft-augmented Posterior Colporrhaphy
A NA study, sponsored by University of California, Irvine.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00581594: Clinical Trial NA study, sponsored by University of California, Irvine.
NCT00581594 is a NA study that was terminated before completion, run by University of California, Irvine. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00581594, a NA study, was terminated before completion, sponsored by University of California, Irvine.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Women who undergo posterior colporrhaphy with graft augmentation will have a lower recurrence of their posterior wall defect than women who undergo a traditional posterior colporrhaphy.
Interventions
- PROCEDURE Graft-augmented colporrhaphy
- PROCEDURE Traditional posterior colporrhaphy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2006-01 |
| Est. Completion | 2008-10-11 |
| Phase | NA |
Why NCT00581594 stopped before completion
NCT00581594 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Graft-augmented colporrhaphy is the first listed.
NCT00581594 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00581594 about?
NCT00581594 is a clinical study titled "Traditional vs. Graft-augmented Posterior Colporrhaphy". Women who undergo posterior colporrhaphy with graft augmentation will have a lower recurrence of their posterior wall defect than women who undergo a traditional posterior colporrhaphy.
What is the current status of trial NCT00581594?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2006-01. Estimated completion is 2008-10-11.
What interventions are being tested in trial NCT00581594?
The interventions under investigation include: Graft-augmented colporrhaphy (PROCEDURE), Traditional posterior colporrhaphy (PROCEDURE).
Who is sponsoring clinical trial NCT00581594?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00581594's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia